New drug to combat debilitating immune system disorder lupus - the condition that left Seal scarred By Ethan Ennals Published: 17:55 EDT, 5 October 2024 | Updated: 17:55 EDT, 5 October 2024 e-mail View comments Patients living with a debilitating immune system disorder that can lead to skin rashes, joint pain and even death are set to receive ground-breaking new treatment. The condition, lupus, affects around 50,000 Britons and can also trigger kidney problems and severe scarring. The award-winning singer Seal, 61, best known for hit Kiss From A Rose, developed a form of the disease in his 20s which left his face permanently marked.
Until recently, there have been few effective treatments. Some available drugs are linked to a number of dangerous side effects, including broken bones and heart disease. The award-winning singer Seal, 61, best known for hit Kiss From A Rose, developed a form of lupus in his 20s which left his face permanently marked Experts believe a new drug could improve sufferers' symptoms (stock photo) But last week, researchers revealed that a new lupus drug triggers 'substantial improvement' in the majority of sufferers.
Read More I was juggling childcare with a busy job and doctors thought I had tonsilitis - but it was cancer Experts believe the once-a-month injection, called dapirolizumab pegol, could soon be available on the NHS. 'This is a first-of-its-kind drug that appears to combat a variety of lupus symptoms,' says Dr Ed Vital of Leeds Institute for.
